| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 29/01/2013 | 17:24 | Zacks | MedTech Industry Stock Outlook - Jan 2013 - Industry Outlook | NYSE:WPI | Actavis, Inc. |
| 24/01/2013 | 15:00 | PR Newswire (US) | Watson Pharmaceuticals, Inc. is Now Actavis, Inc. | NYSE:WPI | Actavis, Inc. |
| 23/01/2013 | 15:29 | PR Newswire (US) | Watson Confirms Opana® ER Patent Challenge | NYSE:WPI | Actavis, Inc. |
| 23/01/2013 | 13:30 | PR Newswire (US) | Watson Acquires Uteron Pharma SA | NYSE:WPI | Actavis, Inc. |
| 22/01/2013 | 17:30 | Zacks | Canada Approves Forest's Bystolic - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 18/01/2013 | 14:00 | PR Newswire (US) | Today's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy | NYSE:WPI | Actavis, Inc. |
| 15/01/2013 | 00:41 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NYSE:WPI | Actavis, Inc. |
| 15/01/2013 | 00:41 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NYSE:WPI | Actavis, Inc. |
| 11/01/2013 | 15:15 | PR Newswire (US) | Watson To Host 2013 Investor Meeting January 25 In New York | NYSE:WPI | Actavis, Inc. |
| 09/01/2013 | 18:00 | Zacks | Forest Settles with Glenmark - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 08/01/2013 | 22:32 | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:WPI | Actavis, Inc. |
| 08/01/2013 | 22:32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NYSE:WPI | Actavis, Inc. |
| 08/01/2013 | 10:36 | Zacks | Stock Market News for January 8, 2013 - Market News | NYSE:WPI | Actavis, Inc. |
| 07/01/2013 | 15:52 | Zacks | Impax Launches Opana ER Generic - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 07/01/2013 | 12:00 | Zacks | Watson's Generic Product Approved - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 04/01/2013 | 19:21 | Zacks | Tough Times Ahead for Endo Health - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 04/01/2013 | 19:17 | Zacks | Patent Challenge for Auxilium Pharma - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 03/01/2013 | 15:00 | PR Newswire (US) | Watson's Generic Lysteda® Receives FDA Approval | NYSE:WPI | Actavis, Inc. |
| 02/01/2013 | 11:00 | Zacks | Watson Files Velcade ANDA - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 28/12/2012 | 15:00 | PR Newswire (US) | Watson Confirms Velcade® Patent Challenge | NYSE:WPI | Actavis, Inc. |
| 28/12/2012 | 14:33 | PR Newswire (US) | EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals | NYSE:WPI | Actavis, Inc. |
| 26/12/2012 | 15:28 | Marketwired | LYB, WPI, SSYS and HW Freshly Hit a New 52-Week High | NYSE:WPI | Actavis, Inc. |
| 21/12/2012 | 15:15 | PR Newswire (US) | Watson to Present at the 31st Annual J.P. Morgan Healthcare Conference | NYSE:WPI | Actavis, Inc. |
| 20/12/2012 | 15:15 | PR Newswire (US) | Watson to Present at 2013 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top | NYSE:WPI | Actavis, Inc. |
| 14/12/2012 | 14:14 | Zacks | An End to Drug Patent Woes? - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 14/12/2012 | 09:20 | Zacks | Endo Cuts EPS View, CEO to Retire - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 06/12/2012 | 14:34 | Zacks | Pharma & Biotech Stock Outlook - Dec 2012 - Industry Outlook | NYSE:WPI | Actavis, Inc. |
| 06/12/2012 | 01:00 | Zacks | Pharma & Biotech Stock Outlook - Dec 2012 - Zacks Analyst Interviews | NYSE:WPI | Actavis, Inc. |
| 04/12/2012 | 12:20 | Zacks | Teva's Guidance Lags Expectations - Analyst Blog | NYSE:WPI | Actavis, Inc. |
| 23/11/2012 | 09:50 | Zacks | Another Generic from Dr. Reddy's - Analyst Blog | NYSE:WPI | Actavis, Inc. |